Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and... see more

TSX:ONC - Post Discussion

Oncolytics Biotech Inc > Early tumor shrinkage improves survival in pancreatic cancer
View:
Post by askretka on Sep 02, 2022 4:34am

Early tumor shrinkage improves survival in pancreatic cancer

https://www.healio.com/news/gastroenterology/20210722/early-tumor-shrinkage-improves-survival-in-pancreatic-cancer --------------------------------------------------------------- 20% Tumor shrinkage is associated with much better survival in Pancreatic Cancer that has no real treatment options. We have 48% average tumor shrinkage in our first 3 patients, so looks pretty interesting. It's early days yet with only 3 patients but we could be onto something really big here. Cheers!!!!!!!!!!!!!!!
Comment by fox7mf on Sep 02, 2022 9:38am
Definitely on to something big, and I submit that, albeit early, the pancreatic results combined with slam dunk ph3 breast, and all the other possible indications, is enough for an astute BP to purchase with little more delay. Pela is derisked like few others.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities